For over 50 years, Bloomberg Tax’s renowned flagship daily news service, Daily Tax Report® has helped leading practitioners and policymakers stay on the cutting edge of taxation and...
April 8 — While the U.S. government's new rules may have killed the tax-inversion deal, cross-border merger activity is likely to continue unabated, analysts and traders said.
“Is this the end of inversion-driven deals? Yes, most likely,” Kevin Smith, an equity sales trader at Makor Securities London, said in an interview. “Is this the end of sizable cross-border merger activity? I really don't think so, as the traditional rationale for such deals—earnings accretion, economies of scale, procurement, etc.—are still very apparent.”
New rules issued April 4 by the Treasury Department make it more difficult to use acquisitions as a way to move U.S. company headquarters abroad to take advantage of jurisdictions with more favorable tax rates. The government has been tightening down on companies that use international addresses to avoid paying the U.S.’s 35 percent corporate income tax rate, the highest in the developed world.
Eighty-two percent of participants in a Bloomberg survey said that tax inversion-motivated mergers and acquisitions will die out after the regulations caused the collapse of Pfizer Inc.’s $160 billion agreement to combine with Allergan Plc, the biggest deal in drug industry history. The merger would have allowed Pfizer to take advantage of Allergan's headquarters in low-tax Ireland.
Nine of the 50 traders, investors and analysts surveyed said that inversion deals would still happen. The rule is designed specifically to discourage “serial” inversions, where foreign companies combine with a number of U.S. companies and then shift their tax addresses overseas.
Total deal volume for U.S. companies acquiring companies in western Europe, where taxes are generally lower, fell by about a third to $34 billion in the first quarter from a year earlier, according to data compiled by Bloomberg. Deal volume globally, coming off last year's record, declined by about 11 percent to $622 billion, according to the data.
Still, cross-border deals accounted for about half of that, up from about a third in the first quarter last year.
While the new Treasury rules don't forbid inversions, it will make them more difficult, and the market is anticipating further action from the U.S. government to prove its determination to prevent these kinds of deals, said Ben Kelly, an event-driven analyst at Louis Capital Markets.
The latest version of the rules also goes after earnings stripping, the practice of moving profits out of the U.S. into low-tax jurisdictions by paying interest to a parent company in another country, a tougher stance than an older proposal, he said.
To contact the reporters on this story: William Canny in London at firstname.lastname@example.org and Trista Kelley in London at email@example.com
To contact the editor responsible for this story: Gaurav Panchal at firstname.lastname@example.org
©2016 Bloomberg L.P. All rights reserved. Used with permission
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)